Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An adenocarcinoma that arises from the periampullary region.
Biomarker and diagnostic research for periampullary adenocarcinoma has been reported in the published literature.
12 clinical trials registered, 4 recruiting. Interventions under study include procedural interventions, drug therapy, other interventions, and biologic therapy. Pipeline includes 3 PHASE3, 1 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT07081360](https://clinicaltrials.gov/study/NCT07081360) |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:00 PM UTC
Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer |
PHASE3 |
Minia University |
RECRUITING |
[NCT06069297](https://clinicaltrials.gov/study/NCT06069297) | Prehabilitation in Pancreatic Surgery | NA | IRCCS San Raffaele | RECRUITING |
[NCT05843877](https://clinicaltrials.gov/study/NCT05843877) | Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula | PHASE3 | Technische Universität Dresden | RECRUITING |
[NCT07009119](https://clinicaltrials.gov/study/NCT07009119) | Laparoscopic Pancreaticoduodenectomy | NA | Minia University | RECRUITING |
88 publications have been identified in PubMed for periampullary adenocarcinoma. Research spans Clinical Trial Publication (36%), Basic Science / Preclinical (18%), and Diagnostic / Biomarker (14%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 32 | 36% |
Laboratory research | 16 | 18% |
Testing and diagnosis research | 12 | 14% |
Disease patterns and progression | 12 | 14% |
Patient case studies | 8 | 9% |
Research summaries | 7 | 8% |
New treatment approaches | 1 | 1% |
Costamagna G (2026). [PMID: 41951900](https://pubmed.ncbi.nlm.nih.gov/41951900/). *Ann Surg Oncol*. [Clinical Trial Publication]
Pecorelli N (2026). [PMID: 41618415](https://pubmed.ncbi.nlm.nih.gov/41618415/). *Trials*. [Clinical Trial Publication]
Verastegui A (2026). [PMID: 40622198](https://pubmed.ncbi.nlm.nih.gov/40622198/). *The American surgeon*. [Clinical Trial Publication]
Yun WG (2026). [PMID: 41651953](https://pubmed.ncbi.nlm.nih.gov/41651953/). *Surgical endoscopy*. [Clinical Trial Publication]
Lopes Júnior JR (2026). [PMID: 41184671](https://pubmed.ncbi.nlm.nih.gov/41184671/). *Surgical endoscopy*. [Diagnostic / Biomarker]
Hajibandeh S (2026). [PMID: 41809357](https://pubmed.ncbi.nlm.nih.gov/41809357/). *World journal of gastrointestinal surgery*. [Basic Science / Preclinical]
Bergenfeldt H (2026). [PMID: 41208312](https://pubmed.ncbi.nlm.nih.gov/41208312/). *Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society*. [Epidemiology / Natural History]
Dupont B (2026). [PMID: 41777617](https://pubmed.ncbi.nlm.nih.gov/41777617/). *Therapeutic advances in gastroenterology*. [Epidemiology / Natural History]
Schouten TJ (2026). [PMID: 41662856](https://pubmed.ncbi.nlm.nih.gov/41662856/). *The lancet. Gastroenterology & hepatology*. [Clinical Trial Publication]
Wongseree K (2026). [PMID: 41717336](https://pubmed.ncbi.nlm.nih.gov/41717336/). *JGH open : an open access journal of gastroenterology and hepatology*. [Clinical Trial Publication]